Strong finish to the financial year for SomnoMed
Filed with ASX · · 1 page · English
Earlier from Somnomed
- Derek Smith appointed Global CEO of SomnoMed
- Results of Institutional Entitlement Offer
- Chairmans Letter
- Continuing High Growth in the Third Quarter
- SomnoMed continues to break records in 4th Quarter
Later from Somnomed
- FDA 510k approval for SomnoDent Alpha
- Sales growth accelerating
- Renew Sleep Solutions opens first two centres in Q2
- Renew Sleep Solutions well ahead of plan
- Strong Q4 growth to finish transitional year
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed